Profund Advisors LLC Cabaletta Bio, Inc. Transaction History

Profund Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$7.22 - $18.82 $253,977 - $662,031	-35,177 Reduced 64.63%	19,250 $143,000
Q1 2024 May 08, 2024	BUY	$16.79 - $25.38 $345,353 - $522,041	20,569 Added 60.75%	54,427 $928,000
Q4 2023 Feb 14, 2024	BUY	$12.21 - $23.36 $167,728 - $320,896	13,737 Added 68.27%	33,858 $768,000
Q3 2023 Nov 13, 2023	BUY	$11.84 - $18.65 $238,232 - $375,256	20,121 New	20,121 $306,000

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $66.4M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Profund Advisors LLC with notifications on news.